Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Blockchain is going to permeate our lives: Matthieu Riou April 11, 2017 First Solid-State LiDAR Unmanned Vehicle Is Unveiled in China June 12, 2018 AutomationDirect introduces Marathon Powerwash SXT motors February 21, 2018